Cargando…
Identification of Novel Cannabinoid CB2 Receptor Agonists from Botanical Compounds and Preliminary Evaluation of Their Anti-Osteoporotic Effects
As cannabinoid CB2 receptors (CB2R) possess various pharmacological effects—including anti-epilepsy, analgesia, anti-inflammation, anti-fibrosis, and regulation of bone metabolism—without the psychoactive side effects induced by cannabinoid CB1R activation, they have become the focus of research and...
Autores principales: | Hu, Si-Jing, Cheng, Gang, Zhou, Hao, Zhang, Qi, Zhang, Quan-Long, Wang, Yang, Shen, Yi, Lian, Chen-Xia, Ma, Xue-Qin, Zhang, Qiao-Yan, Qin, Lu-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8838898/ https://www.ncbi.nlm.nih.gov/pubmed/35163968 http://dx.doi.org/10.3390/molecules27030702 |
Ejemplares similares
-
Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018
por: Finlay, David B., et al.
Publicado: (2022) -
Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB(2)
receptor
por: Patel, Monica, et al.
Publicado: (2023) -
Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
por: Ibsen, Mikkel Søes, et al.
Publicado: (2019) -
Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity
por: Franks, Lirit N., et al.
Publicado: (2016) -
Evaluation of carboxamide-type synthetic cannabinoids as CB(1)/CB(2) receptor agonists: difference between the enantiomers
por: Doi, Takahiro, et al.
Publicado: (2017)